113 related articles for article (PubMed ID: 11831074)
1. [Screening. What documentation should be required?].
Olsen J
Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
[No Abstract] [Full Text] [Related]
2. The ethics of informed consent in relation to prevention screening programmes.
O'Hagan J
N Z Med J; 1991 Mar; 104(908):121-3. PubMed ID: 1901399
[No Abstract] [Full Text] [Related]
3. Cancer screening--benefits, harms and making an informed choice.
Barratt AL
Aust Fam Physician; 2006; 35(1-2):39-42. PubMed ID: 16489385
[TBL] [Abstract][Full Text] [Related]
4. [Present status and problems of mass screening--from the viewpoint of public health].
Miyake K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
[No Abstract] [Full Text] [Related]
5. Decisions on screening for viral markers in blood donors.
Zuck TF
Dev Biol Stand; 1993; 81():91-100. PubMed ID: 8174824
[No Abstract] [Full Text] [Related]
6. Screening for hemoglobin disorders in Thai pregnant women by England and Frazer's calculation method.
Suwansaksri J; Wiwanitkit V; Paritpokee N
Arch Gynecol Obstet; 2004 Dec; 270(4):211-3. PubMed ID: 13680265
[TBL] [Abstract][Full Text] [Related]
7. Glaucoma screening: the value is in the details.
Mills RP
Am J Ophthalmol; 2008 Jan; 145(1):3-4. PubMed ID: 18154749
[No Abstract] [Full Text] [Related]
8. [Screening--what information should potential participants receive?].
Dirksen A
Ugeskr Laeger; 2002 Jan; 164(2):145-7. PubMed ID: 11831073
[No Abstract] [Full Text] [Related]
9. Consent before testing men for prostate cancer--a challenge?
Hirst G
Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
[No Abstract] [Full Text] [Related]
10. [The medical uncertainty--an overlooked reality].
Lunde IM
Lakartidningen; 2002 Oct; 99(41):4068-70. PubMed ID: 12451948
[No Abstract] [Full Text] [Related]
11. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
12. [Screening and intervention. A strategy in type 2 diabetes?].
Jørgensen T; Glümer C; Borch-Johnsen K
Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
[TBL] [Abstract][Full Text] [Related]
13. Screening for gestational diabetes mellitus.
Fink K; Clark B
Am Fam Physician; 2004 Mar; 69(5):1187-8. PubMed ID: 15023021
[No Abstract] [Full Text] [Related]
14. Can you handle the truth (and know it when you see it)? Understanding sensitivity, specificity, predictive values, and ROC curves.
Cotter K; Peipert JF
J Minim Invasive Gynecol; 2005; 12(5):385-90. PubMed ID: 16213422
[TBL] [Abstract][Full Text] [Related]
15. Evaluating validity of screening tests.
Larson E
Nurs Res; 1986; 35(3):186-8. PubMed ID: 3635057
[No Abstract] [Full Text] [Related]
16. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions.
Chen YW; Lin JS; Fong JH; Wang IK; Chou SJ; Wu CH; Lui MT; Chang CS; Kao SY
Br J Oral Maxillofac Surg; 2007 Oct; 45(7):590-1. PubMed ID: 17081665
[TBL] [Abstract][Full Text] [Related]
17. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
18. Child protection: the role of communication.
Scott L
Nurs Times; 2002 Apr 30-May 6; 98(18):34-6. PubMed ID: 12035444
[TBL] [Abstract][Full Text] [Related]
19. Handbook on medical ethics: medical ethics and the practitioner.
Issues Med Ethics; 1996; 4(2):54-8. PubMed ID: 15011679
[No Abstract] [Full Text] [Related]
20. The economic impact of prostate cancer screening and treatment.
DiSantostefano RL; Lavelle JP
N C Med J; 2006; 67(2):158-60. PubMed ID: 16752723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
